
The Liberty Braves Group Series A Financial Ratios 2025-2009 | BATRA
Brief overview of The Liberty Braves Group Series A's market valuation
The comparison uses the five latest available annual observations between 2021 and 2025.
The latest available valuation ratios are EV/EBITDA 9.84x (median 9.84x), P/S 3.17x (median 3.14x), P/B 3.99x (median 2.94x). The combined ratio level is close to the company's five-year norm at a +1.1% deviation. No clear premium or discount is visible.
Capital efficiency is characterized by ROE 7.2%, ROA 3.6%, ROCE 2.7%. Profitability remains low. Market valuation has limited fundamental support until resource returns improve.
On PEG (13.77x), valuation is stretched relative to growth and requires strong execution.
The cash conversion cycle is 26 days versus 26.4 days initially. Turnover changed little.
What the ratios show
The Liberty Braves Group Series A trades near its familiar ratio range. A new earnings or profitability trend is needed to change the view.
Annual Financial Ratios The Liberty Braves Group Series A
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | - | - | - | - | - | -19.6 | 274.5 | -47.0 | -15.1 | - | - | - | - | - | - | - |
P/S |
- | - | - | - | - | - | 3.2 | 3.1 | 3.0 | 3.6 | - | - | - | - | - | - | - |
EPS |
- | - | - | - | - | - | - | - | - | - | 0.2 | 0.5 | 24.7 | 3.9 | - | - | - |
EV (Enterprise Value) |
5.89 B | 3.32 B | 20.5 B | 21.5 B | 22.7 B | -1.55 B | 1.5 B | 1.01 B | 410 M | 586 M | -201 M | -681 M | -1.09 B | -603 M | -970 M | -1.77 B | -3.95 B |
EBITDA per Share |
- | - | - | - | - | - | 0.627 | - | - | - | - | - | - | - | - | - | - |
EV/EBITDA |
9.8 | 8.9 | 30.5 | 37.1 | 7.4 | -32.4 | 60.0 | 22.6 | -36.8 | -39.9 | - | - | - | - | - | -6.1 | - |
PEG |
- | - | - | - | - | 13.77 | 0.01 | 2.29 | -2.18 | 1.01 | - | - | - | - | - | - | - |
P/B |
- | - | - | - | - | - | 4.0 | 3.1 | 2.8 | 2.3 | - | - | - | - | - | - | - |
P/CF |
- | - | - | - | - | - | -53.9 | 19.6 | -4.5 | -3.5 | - | - | - | - | - | - | - |
ROE % |
7.15 | -29.35 | 4.64 | 11.37 | 2.71 | -7.25 | -20.37 | 1.14 | -5.85 | -15.50 | - | - | - | - | - | 20.00 | - |
ROA % |
3.60 | -15.87 | 1.84 | 4.27 | 0.90 | -90.45 | -4.83 | 0.28 | -1.34 | -4.01 | - | - | - | - | - | - | - |
ROCE % |
2.66 | 0.33 | 1.62 | 0.91 | 13.47 | 0.90 | -2.78 | 0.06 | -6.37 | -4.42 | - | - | - | - | - | 3.90 | - |
Current Ratio |
2.2 | 2.2 | 1.9 | 1.8 | 1.7 | 1.2 | 1.4 | 3.1 | 2.4 | 0.8 | - | - | - | - | - | - | - |
DSO |
26.0 | 37.1 | 49.0 | 96.1 | 26.4 | 31.0 | 21.5 | 17.3 | 30.3 | 20.9 | - | - | - | - | - | - | - |
Operating Cycle |
26.0 | 37.1 | 49.0 | 96.1 | 26.4 | 31.0 | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
26.0 | 37.1 | 49.0 | 96.1 | 26.4 | 31.0 | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios The Liberty Braves Group Series A
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.09 | 0.13 | -0.07 | 0.18 | -0.06 | 0.21 | 0.1 | 0.15 | 0.06 | 1.62 | 0.21 | 0.26 | 22.57 | 0.88 | 1.86 | 7.87 | 1.24 | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.59 | - | 1.24 | 0.78 | 0.96 | - | 0.99 | 0.95 | 0.72 | - | 0.92 | 0.88 | 1.86 | - | 0.18 | 0.11 | -0.19 | - | - | - | - |
ROE % |
3.76 | 3.76 | -28.82 | -26.32 | -27.87 | -25.57 | 7.83 | 5.24 | 6.57 | 7.59 | 7.37 | 7.28 | 9.01 | 9.26 | 5.08 | 3.75 | 2.99 | -0.91 | -4.21 | -3.42 | -3.30 | -1.36 | 1.52 | 1.05 | 1.11 | 1.54 | 1.87 | 3.63 | 11.87 | 11.25 | 10.77 | 9.86 | 3.00 | 2.99 | 3.13 | 6.35 | 5.17 | 4.00 | 3.86 | 0.59 | 0.82 | 1.31 | 1.19 | 1.56 | 4.84 | 5.09 | 5.31 | 62.35 | 60.08 | 62.97 | 76.86 | 21.96 | 3.43 | 14.55 | 2.33 | - | - | - | - |
ROA % |
1.94 | 1.95 | -16.34 | -15.34 | -16.34 | -15.45 | 3.07 | 2.04 | 2.46 | 2.07 | 2.22 | 2.18 | 3.10 | 2.19 | 1.93 | 1.39 | 1.13 | -0.35 | -1.43 | -1.17 | -1.13 | -0.43 | 0.57 | 0.39 | 0.42 | 0.64 | 0.80 | 1.47 | 4.80 | 4.54 | 4.35 | 3.98 | 1.17 | 1.13 | 1.17 | 2.38 | 1.94 | 1.50 | 1.44 | 0.21 | 0.31 | 0.49 | 0.44 | 0.58 | 1.93 | 2.05 | 2.16 | 25.42 | 25.09 | 27.53 | 38.51 | 16.98 | 2.65 | 11.26 | 1.80 | - | - | - | - |
ROCE % |
7.72 | 5.56 | 6.17 | 7.24 | 6.56 | 11.44 | 13.21 | 12.25 | 12.51 | 11.67 | 11.04 | 8.91 | 12.62 | 13.50 | 11.44 | 8.86 | 10.98 | 8.68 | 6.14 | 5.17 | 7.02 | 8.01 | 9.42 | 9.02 | 9.45 | 9.54 | 8.96 | 9.11 | 8.77 | 7.83 | 8.07 | 8.23 | 8.60 | 9.34 | 9.64 | 14.75 | 14.41 | 14.35 | 13.13 | 8.73 | 8.55 | 7.80 | 8.26 | 7.38 | 6.91 | 6.49 | 6.07 | 5.78 | 3.51 | 1.90 | 0.33 | -1.24 | 5.26 | 0.03 | -0.50 | 5.57 | - | - | - |
Current Ratio |
2.1 | 2.1 | 1.8 | 2.1 | 2.1 | 2.3 | 1.9 | 1.9 | 1.9 | 1.8 | 1.8 | 1.8 | 1.8 | - | 1.7 | 1.7 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 2.0 | 2.0 | 2.0 | 2.0 | 2.1 | 2.1 | 2.1 | 2.1 | 2.2 | 2.2 | 2.2 | 2.2 | 2.3 | 2.3 | 2.3 | 2.3 | 2.5 | 2.5 | 2.5 | 2.5 | 3.0 | 2.8 | 2.8 | 2.8 | 3.2 | 3.2 | 3.2 | 3.2 | 4.4 | 4.4 | 4.4 | 4.4 | 3.1 | - | - | - |
DSO |
25.2 | 36.3 | 18.8 | 9.8 | 27.1 | 47.5 | 23.3 | 26.5 | 23.2 | 21.4 | 27.4 | - | 11.6 | 11.8 | 29.6 | - | 24.1 | 25.4 | 32.4 | - | 27.5 | 39.3 | 36.0 | 26.7 | 24.5 | 24.9 | 25.6 | 16.5 | 14.3 | 15.1 | 21.7 | 16.4 | 15.8 | 15.3 | 19.6 | 16.6 | 15.8 | 16.0 | 18.4 | 18.7 | 17.6 | 18.4 | 20.3 | 19.6 | 18.1 | 18.5 | 19.9 | 18.3 | 16.9 | 17.4 | 13.4 | 51.9 | 14.8 | 16.9 | 408.0 | 13.5 | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 269.6 | 216.3 | 1312.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | 21.4 | 27.4 | - | 11.6 | 11.8 | 29.6 | - | 24.1 | 25.4 | 32.4 | - | 27.5 | 39.3 | 36.0 | 26.7 | 24.5 | 24.9 | 25.6 | 16.5 | 14.3 | 15.1 | 21.7 | 16.4 | 15.8 | 15.3 | 19.6 | 16.6 | 15.8 | 16.0 | 18.4 | 18.7 | 17.6 | 18.4 | 20.3 | 19.6 | 18.1 | 18.5 | 19.9 | 18.3 | 16.9 | 17.4 | 13.4 | 51.9 | 14.8 | 16.9 | 408.0 | 13.5 | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | 21.4 | 27.4 | - | 11.6 | 11.8 | 29.6 | - | 24.1 | 25.4 | 32.4 | - | 27.5 | 39.3 | 36.0 | 26.7 | 24.5 | 24.9 | 25.6 | 16.5 | 14.3 | 15.1 | 21.7 | 16.4 | -253.8 | -201.1 | -1292.8 | 16.6 | 15.8 | 16.0 | 18.4 | 18.7 | 17.6 | 18.4 | 20.3 | 19.6 | 18.1 | 18.5 | 19.9 | 18.3 | 16.9 | 17.4 | 13.4 | 51.9 | 14.8 | 16.9 | 408.0 | 13.5 | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company The Liberty Braves Group Series A, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.